Nektar Therapeutics (USA) holds 2 active US FDA Type II Drug Master Files and 7 inactive and holds 0 active Type IV (excipient) Drug Master Files. No FDA recall, Warning Letter or Form 483 record is linked to it, which is not proof that none exists.

Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records

Cite as: PharmaTek, “Nektar Therapeutics: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/nektar-therapeutics

Overview

Nektar Therapeutics is a biopharmaceutical company developing a portfolio of drug candidates that leverage its PEGylation and polymer conjugate technology platforms. The company's research is focused on treatments for cancer, autoimmune disease, and chronic pain.

Therapeutic areas

API / Drug Master Files

Nektar Therapeutics holds 2 active (9 total) FDA Type II Drug Master Files. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.

  • NKTR-255 DRUG PRODUCTActive2019-12-13
  • NKTR-255 DRUG SUBSTANCEActive2019-10-01
  • N-HYDROXYSUCCINIMIDYL ESTER OF BIS (METHOXYPOLY(ETHYLENE GLYCOL) MW 20,000) MODIFIED LYSINEInactive2010-05-07
  • AMIKACIN PULMONARY DELIVERY SYSTEMInactive2007-10-31
  • PEG2NHS40KPInactive2006-02-06
  • PEG2MAL40KInactive2006-01-27
  • METHOXYPOLY (ETHYLENE GLYCOL)- SUCCINIMIDYL BUTANOATE, MW 30,000 (MSBA30K)Inactive2001-08-06
  • METHOXYPOLY (ETHYLENE GLYCOL)- PROPIONALDEHYDE, MW 20, 000Inactive2000-11-10
  • METHOXYPOLY (ETHYLENE GLYCOL)- SUCCINIMIDYL CARBONATE, MW 12,000Inactive2000-06-02

Excipient Drug Master Files

Nektar Therapeutics holds 0 active (1 total) FDA Type IV Drug Master File. A Type IV DMF covers an excipient, colourant or flavour, not an active ingredient; these are counted separately from the API filings above.

  • MPEG5000 DPPEInactive1998-09-23

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to Nektar Therapeutics in our records. Events are linked by company name and identifier, so this is not proof that none exist; check the FDA's own databases before relying on it.

For suppliers

Is this Nektar Therapeutics?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.

Need suppliers found and checked?

The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.